Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a simple cream soothe psoriasis itch? small trial hopes to find out

NCT ID NCT06800755

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested a moisturizing medical device called RL3020-DP0364 (Dexeryl) in 40 adults with stable mild plaque psoriasis, dry skin, and itching. Participants applied the cream to their whole body (except head) for about a month. The main goal was to see if it reduced itch intensity. The trial is finished, but results are not yet reported.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dexeryl (RL3020-DP0364) moisturizing cream
What this could lead to
If it works, this cream could offer a simple, non-drug way to reduce itching and dryness in people with mild psoriasis.
What could go wrong
This is a small, completed trial with only 40 people, so results may not apply to everyone. It is a moisturizer, not a treatment for psoriasis itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Feb 2025

Finished

Jul 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Subject with stable mild plaque psoriasis covering ≤ 10% BSA (Body Surface Area; excluding the head\*) * Subject whose plaque psoriasis has been diagnosed for at least 6 months before the inclusion visit * Subject with dry skin according to the investigator assessment * Subject with a pruritus intensity (on average over the previous 24 hours) ≥ 3 on a Numerical Rating Scale (NRS) between 0 and 10 (with 0 = no pruritus and 10 = worst imaginable pruritus) on the body\* * the head is not included in the evaluated area Exclusion criteria: Criteria related to the disease: * Subject with erythrodermic psoriasis, pustular psoriasis * Subject with palmoplantar keratoderma * Subject with any other aetiology of pruritus, not related to plaque psoriasis * Subject with history of allergy or intolerance to any of the tested product ingredients * Subject having any other dermatologic condition than psoriasis, or characteristics (like tattoo, wound…) on body liable to interfere with the study assessments * Subject having an acute, chronic or progressive disease or history of disease liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements Criteria related to treatments and/or products: * Biotherapy treatment in the 6 months prior to the inclusion visit or ongoing or planned to be started during the study * Other systemic treatment for psoriasis (acitretin, cyclosporine, methotrexate, apremilast...) in the 3 months prior to the inclusion visit or ongoing or planned to be started during the study * Phototherapy treatment in the 4 weeks prior to the inclusion visit or ongoing or planned to be started during the study * Any other systemic treatment incompatible with the study or liable to interfere with the study assessments according to the investigator, in the weeks prior to the inclusion visit, ongoing or planned to be started during the study * Topical treatment for psoriasis (corticosteroid, vitamin D analogs…) applied on the body\* in the 4 weeks prior to the inclusion visit or ongoing or planned to be started during the study * Topical product (including any moisturizer, emollient, keratolytic …) applied on the body\* in the 7 days prior to the inclusion visit or ongoing or planned to be started during the study * Any product applied on the body\* before the visit, the day of inclusion visit * Any other topical treatment or product applied on the body\* incompatible with the study or liable to interfere with the study assessments according to the investigator, in the weeks prior to the inclusion visit, ongoing or planned to be started during the study * the head is not included in the evaluated area

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dry skin are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pruritus psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dermscan Poland

    Gdansk, Poland, 80288, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.